SINGAPORE, May 29, 2014 /CNW/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical,
industrial and scientific markets, today announced it has completed the
initial design engineering for a new data processing module for its
patented real-time 3D display, representing a significant milestone in
bringing the display system to commercial production. The new
configuration provides for real time capability, with a system capable
of transferring data for up to ninety views in full High Definition.
The new system design eliminates the previous requirement for ALP (accessory light modulator package) boards, allowing for a significantly cheaper and more compact design.
The redesign also includes the development of 3D image compression for
data interface, and a new application interface to allow direct
transfer of data from existing programs such as AutoCAD. These recent
developments directly support Zecotek's recent initiative in developing
new 3D printers and 3D printer interfaces.
"There is a substantial latent demand for a commercially viable,
glasses-free, true 3D HD system which can handle real time data from a
variety of existing sources and can adapt to either small workstations
or large venue screens." said Dr. A.F. Zerrouk, Chairman, President,
and CEO of Zecotek Photonics Inc. "The new design represents a
significant cost and performance breakthrough for our patented 3D
display technology and importantly provides a core technology to both
front or rear projection displays, where we have also overcome the
technical barriers associated with early designs, which relied on an
electromechanical interface."
Zecotek has received patent allowances from the United States, Europe
and Eurasia covering the 3D/2D switchable optical imaging system of
Zecotek's 3D Display. The 3D/2D switchable optical imaging system
further improves the core capabilities of the 3D display technology by
introducing a software-selectable full-resolution 2D mode with viewing
angles and dynamic range/colour depth on par with conventional 2D
displays. The patent also covers technology for both 3D and 2D modes,
dynamic adjustment of viewing angle, number and width of viewing zones
as well as the functionality to dynamically control the positioning of
different viewing zones.
Patents have been granted to Zecotek for its 3D display system in the
United States, China, Europe, Eurasia, Russia and Australia. Other
patents have been filed and are pending in Japan, Korea and India.
About Zecotek's 3D Display System
Zecotek's 3D Display System is based on the auto-stereoscopic principle,
but with substantial innovative and patented improvements and
represents a new and unique generation of 3D displays. It has the
capability of simultaneously presenting 3D and 2D images on the same
screen, and for separate views at different viewing angles. Zecotek's
true, auto-stereoscopic 3D2D display system requires no eyewear and has
an effective viewing angle of 40 degrees with 90 concurrent
perspectives allowing for multiple views at the same time. Another
unique feature of the Zecotek system is constant motion parallax within
the viewing angle. Motion parallax eliminates the sense of imbalance
and dizziness during normal observation which can occur with polarized
and shutter glasses used with other commercial systems.
Furthermore Zecotek's 3D display features the preservation of the base
resolution in every perspective view irrespective of the number of such
views. This is not true for any other glasses-free displays where the
base resolution is divided by the number of views. Zecotek`s white
paper on 3D display technology is available on www.zecotek.com.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical,
high-tech and industrial sectors. Founded in 2004, Zecotek operates
three divisions: Imaging Systems, Laser Systems and 3D Display Systems
with labs located in Canada, Korea, Russia, Singapore and U.S.A. The
management team is focused on building shareholder value by
commercializing over 50 patented and patent pending novel photonic
technologies directly and through strategic alliances and joint
ventures with leading industry partners such as Hamamatsu Photonics
(Japan), the European Organization for Nuclear Research (Switzerland),
Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical
Systems (South Korea), and National NanoFab Center (South Korea). For
more information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based
on management's expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to predict.
Therefore, actual future results and trends may differ materially from
what may have been stated.
The TSX Venture 50® are the top 10 companies listed on the TSX Venture
Exchange, in each of five major industry sectors - mining, oil & gas,
technology & life sciences, diversified industries and clean technology
- based on a ranking formula with equal weighting given to return on
investment, market cap growth, trading volume and analyst coverage. All
data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of
this news release. If you would like to receive news from Zecotek in
the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
Image with caption: "Zecotek - Leading the Way in Photonics (CNW Group/Zecotek Photonics Inc.)". Image available at: http://photos.newswire.ca/images/download/20140529_C7463_PHOTO_EN_40876.jpg